• Montefiore-Einstein Scientists Lead Two Trials of Leronlimab americanpharmaceuticalreview
    May 28, 2020
    Montefiore Health System and Albert Einstein College of Medicine are the evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19, and the other to treat severely ill COVID-19 patients.
PharmaSources Customer Service